Immunic, Inc.IMUXNASDAQ
Loading
Year-over-year net income growth rate
5Y CAGR
+12.6%/yr
Long-term compound
Percentile
P87
Within normal range
vs 5Y Ago
1.8x
Solid growth
Streak
2 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 24.55% |
| Q3 2025 | 4.63% |
| Q2 2025 | -5.29% |
| Q1 2025 | -1.18% |
| Q4 2024 | -3.31% |
| Q3 2024 | -13.98% |
| Q2 2024 | 27.73% |
| Q1 2024 | -37.14% |
| Q4 2023 | 5.26% |
| Q3 2023 | 5.13% |
| Q2 2023 | 5.04% |
| Q1 2023 | 55.25% |
| Q4 2022 | -166.09% |
| Q3 2022 | 3.09% |
| Q2 2022 | -5.25% |
| Q1 2022 | 1.78% |
| Q4 2021 | -9.81% |
| Q3 2021 | -7.57% |
| Q2 2021 | 48.07% |
| Q1 2021 | -209.47% |
| Q4 2020 | 13.58% |
| Q3 2020 | -12.70% |
| Q2 2020 | -35.01% |
| Q1 2020 | -10.35% |
| Q4 2019 | 6.38% |
| Q3 2019 | 44.17% |
| Q2 2019 | -55.00% |
| Q1 2019 | -285.27% |
| Q4 2018 | 79.37% |
| Q3 2018 | 5.84% |
| Q2 2018 | 11.86% |
| Q1 2018 | 1.37% |
| Q4 2017 | -16.88% |
| Q3 2017 | -0.60% |
| Q2 2017 | 1.55% |
| Q1 2017 | -7.40% |
| Q4 2016 | -15.29% |
| Q3 2016 | -7.50% |
| Q2 2016 | 1.26% |
| Q1 2016 | 2.74% |